THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE

This article analyzes the legal assessment of the human genome modification experiment at the pre-implantation stage conducted by a group of scientists headed by He Jiankui, professor at the Southern University of Science and Technology (SUSTech) in Shenzhen, Guangdong Province, China, by means of t...

Full description

Bibliographic Details
Main Author: D. Sergeev
Format: Article
Language:English
Published: Publshing House V.Ема 2019-11-01
Series:BRICS Law Journal
Subjects:
Online Access:https://www.bricslawjournal.com/jour/article/view/272
_version_ 1797855843187687424
author D. Sergeev
author_facet D. Sergeev
author_sort D. Sergeev
collection DOAJ
description This article analyzes the legal assessment of the human genome modification experiment at the pre-implantation stage conducted by a group of scientists headed by He Jiankui, professor at the Southern University of Science and Technology (SUSTech) in Shenzhen, Guangdong Province, China, by means of the CRISPR/Cas9 technology. Chinese scholars have different opinions concerning He Jiankui’s experiment, but on the whole condemn it as illegal. Though CRISPR/Cas9 has been applied for quite a long time, the legislation of most developed countries is not ready to respond. The author of the article underlines the fact that despite the consolidated opinion of scholars, there is no binding international act which would restrict human genome editing. The author relies on Chinese sources in considering the main approaches to the assessment of He Jiankui’s actions in terms of criminal law (illegal medical activity, forgery of documents or fraud). Based on the analysis of Chinese criminal law doctrine, the author offers possible models of classifying separate actions related to human genome manipulation. The following cases of human genome manipulation are considered by the author as publicly dangerous and criminally liable: (a) when the embryo genome is changed by genetic engineering technologies for the purpose of its further implantation in the situation where the child’s parents are not aware of such intervention and its possible implications; (b) when genetic therapy or any other gene transfer (transgenesis) is applied to a person who is not aware of the nature of such manipulation and the possible implications of the application of the technology.
first_indexed 2024-04-09T20:30:35Z
format Article
id doaj.art-edc66f27496349a4994aa04f73377ce6
institution Directory Open Access Journal
issn 2409-9058
2412-2343
language English
last_indexed 2024-04-09T20:30:35Z
publishDate 2019-11-01
publisher Publshing House V.Ема
record_format Article
series BRICS Law Journal
spelling doaj.art-edc66f27496349a4994aa04f73377ce62023-03-30T20:04:01ZengPublshing House V.ЕмаBRICS Law Journal2409-90582412-23432019-11-016411413310.21684/2412-2343-2019-6-4-114-133150THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVED. Sergeev0Ural State Law UniversityThis article analyzes the legal assessment of the human genome modification experiment at the pre-implantation stage conducted by a group of scientists headed by He Jiankui, professor at the Southern University of Science and Technology (SUSTech) in Shenzhen, Guangdong Province, China, by means of the CRISPR/Cas9 technology. Chinese scholars have different opinions concerning He Jiankui’s experiment, but on the whole condemn it as illegal. Though CRISPR/Cas9 has been applied for quite a long time, the legislation of most developed countries is not ready to respond. The author of the article underlines the fact that despite the consolidated opinion of scholars, there is no binding international act which would restrict human genome editing. The author relies on Chinese sources in considering the main approaches to the assessment of He Jiankui’s actions in terms of criminal law (illegal medical activity, forgery of documents or fraud). Based on the analysis of Chinese criminal law doctrine, the author offers possible models of classifying separate actions related to human genome manipulation. The following cases of human genome manipulation are considered by the author as publicly dangerous and criminally liable: (a) when the embryo genome is changed by genetic engineering technologies for the purpose of its further implantation in the situation where the child’s parents are not aware of such intervention and its possible implications; (b) when genetic therapy or any other gene transfer (transgenesis) is applied to a person who is not aware of the nature of such manipulation and the possible implications of the application of the technology.https://www.bricslawjournal.com/jour/article/view/272he jiankuigenome editinggeneticscriminal law of chinacriminal liabilitypublic danger
spellingShingle D. Sergeev
THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE
BRICS Law Journal
he jiankui
genome editing
genetics
criminal law of china
criminal liability
public danger
title THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE
title_full THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE
title_fullStr THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE
title_full_unstemmed THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE
title_short THE FIRST CASE OF HUMAN GENOME EDITING: CRIMINAL LAW PERSPECTIVE
title_sort first case of human genome editing criminal law perspective
topic he jiankui
genome editing
genetics
criminal law of china
criminal liability
public danger
url https://www.bricslawjournal.com/jour/article/view/272
work_keys_str_mv AT dsergeev thefirstcaseofhumangenomeeditingcriminallawperspective
AT dsergeev firstcaseofhumangenomeeditingcriminallawperspective